Page last updated: 2024-10-21

monomethylpropion and Acquired Immunodeficiency Syndrome

monomethylpropion has been researched along with Acquired Immunodeficiency Syndrome in 1 studies

monomethylpropion: metabolite of dimethylpropion; structure given in first source
2-methylamino-1-phenylpropan-1-one : An aromatic ketone that is propiophenone in which the hydrogen alpha- to the keto group has been replaced by a methylamino group.
methcathinone : A racemate comprising equal amounts of (R)- and (S)-methcathinone.

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stepens, A1
Logina, I1
Liguts, V1
Aldins, P1
Eksteina, I1
Platkājis, A1
Mārtinsone, I1
Tērauds, E1
Rozentāle, B1
Donaghy, M1

Other Studies

1 other study available for monomethylpropion and Acquired Immunodeficiency Syndrome

ArticleYear
A Parkinsonian syndrome in methcathinone users and the role of manganese.
    The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Age of Onset; Drug Contamination; Female; Globus Pallidus

2008